Quick Answer
HCA Healthcare, Inc. reported Cash and Equivalents of $1.04 billion for fiscal year 2025.
HCA Healthcare, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.04B | -46.2% |
| 2024 | $1.93B | +106.7% |
| 2023 | $935.00M | +3.0% |
| 2022 | $908.00M | -37.4% |
| 2021 | $1.45B | -19.1% |
| 2020 | $1.79B | +188.7% |
| 2019 | $621.00M | +23.7% |
| 2018 | $502.00M | -31.4% |
| 2017 | $732.00M | +13.3% |
| 2016 | $646.00M | -12.8% |
| 2015 | $741.00M | +30.9% |
| 2014 | $566.00M | +36.7% |
| 2013 | $414.00M | -41.3% |
| 2012 | $705.00M | +89.0% |
| 2011 | $373.00M | -9.2% |
| 2010 | $411.00M | +31.7% |
| 2009 | $312.00M | -32.9% |
| 2008 | $465.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $997.00M | -65.5% | +6.2% |
| June 30, 2025 | $939.00M | +13.0% | -11.4% |
| March 31, 2025 | $1.06B | -17.4% | -45.2% |
| December 31, 2024 | $1.93B | +106.7% | -33.1% |
| September 30, 2024 | $2.89B | +224.1% | +247.5% |
| June 30, 2024 | $831.00M | -3.6% | -35.3% |
| March 31, 2024 | $1.28B | +52.5% | +37.3% |
| December 31, 2023 | $935.00M | +3.0% | +4.9% |
- HCA Healthcare, Inc. showed a decrease of -46.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, HCA Healthcare, Inc.’s cash and equivalents has grown by 123.7% (from $465.00 million to $1.04 billion).
- The most recent figure is from HCA Healthcare, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: